Nitrolingual (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitrolingual, is a nitrate presented as a sublingual formulation for sublingual use. It is employed to relieve episodes of angina pectoris and to manage acute coronary syndrome in adult patients by rapidly dilating coronary vessels and reducing myocardial oxygen demand. It acts within minutes, providing prompt symptom relief and is commonly stored for emergency use.

GNH USA supplies Nitrolingual as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Nitrolingual (glyceryl trinitrate) is a nitrate used in the management of coronary artery disease and related ischemic conditions. - Angina pectoris: provides rapid relief of chest pain by dilating coronary vessels and decreasing cardiac workload. - Acute coronary syndrome: stabilises myocardial oxygen supply during an acute event. - Variant (Prinzmetal) angina: prevents coronary spasm and associated chest discomfort.

Nitrolingual may cause a range of adverse reactions. Patients should be informed of typical and serious possibilities.

Common Side Effects: - Headache: throbbing pain often triggered by vasodilation. - Flushing: warmth and redness of the skin. - Hypotension: transient drop in blood pressure. - Dizziness or light‑headedness. - Nausea: mild gastrointestinal upset. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Severe hypotension: may lead to syncope. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare but possible in high‑risk patients. - Allergic reaction: rash, itching, or swelling. - Methemoglobinemia: abnormal hemoglobin affecting oxygen delivery.

Before prescribing Nitrolingual, clinicians should consider several safety aspects. - Severe anemia: avoid use due to increased risk of methemoglobinemia. - Concomitant phosphodiesterase‑5 inhibitors: may cause profound hypotension. - Blood pressure monitoring: observe for significant drops after administration. - Hypertrophic cardiomyopathy: use with caution as outflow obstruction may worsen. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Nitrolingual can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Sildenafil, tadalafil, and other PDE5 inhibitors: risk of severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect. - Sodium nitroprusside: excessive vasodilation leading to critical blood pressure fall.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia response. - Calcium channel blockers: additive blood pressure lowering. - Alcohol: enhances hypotensive effect.